VSX1 Antibody

說明書

中文名稱：

VSX1兔多克隆抗體
貨號：

CSB-PA025938ESR1HU
規(guī)格：

￥440
圖片：
Western blot
All lanes: VSX1 antibody IgG at 2.32μg/ml + 293T whole cell lysate
Secondary
Goat polyclonal to rabbit IgG at 1/10000 dilution
Predicted band size: 39, 25, 40, 15, 30, 23, 25, 33 kDa
Observed band size: 39 kDa
其他：

產(chǎn)品詳情
產(chǎn)品評價
相關(guān)產(chǎn)品
靶點詳情

產(chǎn)品詳情

產(chǎn)品名稱：

Rabbit anti-Homo sapiens (Human) VSX1 Polyclonal antibody
Uniprot No.：

Q9NZR4
基因名：

VSX1
別名：

VSX1 antibody; RINX antibody; Visual system homeobox 1 antibody; Homeodomain protein RINX antibody; Retinal inner nuclear layer homeobox protein antibody; Transcription factor VSX1 antibody
宿主：

Rabbit
反應(yīng)種屬：

Human
免疫原：

Recombinant Human Visual system homeobox 1 protein (1-170AA)
免疫原種屬：

Homo sapiens (Human)
標(biāo)記方式：

Non-conjugated
克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

Antigen Affinity Purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA, WB

推薦稀釋比：

Application	Recommended Dilution
WB	1:1000-1:5000

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點詳情

功能：

Binds to the 37-bp core of the locus control region (LCR) of the red/green visual pigment gene cluster. May regulate the activity of the LCR and the cone opsin genes at earlier stages of development. Dispensable in early retinal development.
基因功能參考文獻：
1. In this study, we added one novel missense sequence variation (p.Arg131Pro) in the coding region of the VSX1 gene to the range of VSX1 coding region variations observed in patients with sporadic keratoconus from China. PMID: 28950846
2. The aim of this study was to screen the visual system homeobox 1 (VSX1) gene in Turkish patients with keratoconus PMID: 27819732
3. We cannot confirm the previously reported association of the polymorphism in the VSX1 gene with keratoconus (KC). Our results suggest a possible causative role of SOD1 in the pathogenesis of KC. PMID: 24099280
4. novel missense substitutions in the VSX1 gene: clinical and genetic analysis of families with Keratoconus from India PMID: 25963163
5. Our findings confirmed previous reports that polymorphisms of VSX1 and IL1A genes were associated with risk of keratoconus in the Chinese population PMID: 23289806
6. Our investigation showed that Keratoconus-related VSX1 mutations were found in a very small proportion of the studied patients from Iran. PMID: 24107477
7. This study reports the presence of pathogenic mutations in VSX1 in posterior polymorphous dystrophy and keratoconus. PMID: 23592923
8. lack of VSX1 pathogenic variations in a large number of unrelated sporadic keratoconus patients tend to omit its role, and corroborate the involvement of other genetic, environmental or behavioural factors in the development of this complex disorder PMID: 23506487
9. Our results suggest that the VSX1 gene and its mutations with amino acid changes do not play a major role in the pathogenesis of keratoconus. PMID: 22531431
10. A significant association between keratoconus patients and VSX1 genetic alterations, is reported. PMID: 22171159
11. A novel mutation p.G239R and previously reported mutations were found in VSX1 in Italian patients with keratoconus. PMID: 21976959
12. VSX1 may have an important role in the pathogenesis of keratoconus. PMID: 21365019
13. In the keratoconus cohort, no pathogenic VSX1 mutation(s) were identified. PMID: 21403853
14. VSX1has a minor role in keratoconus pathogenesis. PMID: 19763142
15. In mice, Vsx1 mRNA, protein or reporter gene expression is not detected in the normal or damaged cornea. PMID: 21437200
16. No pathogenic VSX1 mutation was identified. PMID: 21139977
17. The absence of pathogenic mutations in VSX1 gene in our large number of unrelated keratoconus patients indicates that other genetic factors are involved in the development of this disorder PMID: 20664914
18. The absence of pathogenic mutations in our large number of unrelated patients with KC (keratoconus) indicates that other genetic factors are involved in the development of this disorder. PMID: 20023586
19. Mutations in VSX1 homeobox gene results in impaired DNA binding and is associated with posterior polymorphous dystrophy and keratoconus PMID: 11978762
20. The new mutation in the VSX1 (RINX) gene described in this report results in abnormal craniofacial features, absence of the roof of the sella turcica, and anomalous development of the corneal endothelium. PMID: 15051220
21. Mutational analysis of the VSX1 gene in a series of Italian patients revealed one novel mutation and confirmed an important role played by this gene in a significant proportion of patients affected by keratoconus PMID: 15623752
22. CHX10 and VSX1 may control retinal bipolar cell specification or differentiation by repressing genes required for the development of other cell types PMID: 15647262
23. The human VSX1 is required for cone ON bipolar cell function but not for rod and cone OFF bipolar cells, giving a unique example of such a selective heritable retinal defect in humans. PMID: 16384943
24. The absence of pathogenic mutations in the VSX1 gene in a large number of unrelated KTCN (keratoconus) patients indicates that other genetic factors are involved in the development of this disorder. PMID: 16799019
25. The results show that VSX1 is expressed in vitro and in vivo during human corneal wound healing, a process in which differentiation of corneal keratocytes into myofibroblasts occurs. PMID: 17122109
26. We excluded c.432C>G sequence alteration as cause. Involvement of this gene in pathogenesis of keratoconus is likely to be confined to a small number of pedigrees. PMID: 17960127
27. We cannot confirm the previously reported association of the polymorphism in the VSX1 gene with keratoconus. PMID: 18216574
28. First documentation of VSX1 expression in human neonatal cornea. Full genomic sequence of VSX1 and coding exons of three other candidate genes were excluded from being pathogenic in original posterior polymorphous corneal dystrophy family. PMID: 18253095
29. VSX1 gene mutation is associated with keratoconus PMID: 18484309
30. VSX1 gene variants seem to be significant genetic variants for keratoconus predisposition in unrelated Korean patients. PMID: 18626569
31. The results exclude VSX1 and SOD1 as potential disease-causing genes in these families and localize a novel gene for keratoconus to a 5.6-Mb interval on 13q32. PMID: 19011015
32. The absence of pathogenic mutations in the VSX-1 gene in affected family members of 3 pedigrees indicates that other genetic factors are involved in the development of familial Fuchs endothelial corneal dystrophy. PMID: 19507099
33. This is the first report from the Indian subcontinent exploring the role of VSX1 in the causation of keratoconus. PMID: 19956409
顯示更多

收起更多
相關(guān)疾病：

Keratoconus 1 (KTCN1); Craniofacial anomalies and anterior segment dysgenesis syndrome (CAASDS)
亞細胞定位：

Nucleus.
蛋白家族：

Paired homeobox family
組織特異性：

In the adult eye, expressed in lens, iris, ciliary body, choroid, optical nerve head and, most strongly, in retina, but not expressed in sclera and cornea. According to PubMed:11978762, expressed in adult retina but not in lens and cornea. Within adult re
數(shù)據(jù)庫鏈接：

HGNC: 12723

OMIM: 148300

KEGG: hsa:30813

STRING: 9606.ENSP00000365899

UniGene: Hs.274264

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human